Skip to main content
SpringerLink
Log in

Quality of Life Outcomes in Radiotherapy of Lung Cancer

  • Chapter
  • First Online:
Advances in Radiation Oncology in Lung Cancer

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1742 Accesses

Abstract

Lung cancer is one of the most common cancers in the world. There has been an increased interest in quality of life (QOL) as a clinically meaningful endpoint in clinical trials for lung cancer. Patient-reported outcome (PRO) measurements have allowed oncologists to better understand the impact of cancer therapies on the physical, emotional and social well-being of their patients. This chapter provides a review of the clinical relevance, measurement, analysis and challenges of quality of life in lung cancer trials. A summary of salient quality-of-life studies, particularly involving radiation treatment for lung cancer, is included.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Aaronson N, Fayers P (eds) (2002) Quality of life. Oxford textbook of oncology. Oxford University Press, Oxford

    Google Scholar 

  • Aaronson NK, Ahmedzai S et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376

    Article  PubMed  CAS  Google Scholar 

  • Basch E, Iasonos A et al (2006) Patient versus clinician symptom reporting using the national cancer institute common terminology criteria for adverse events: results of a questionnaire-based study. Lancet Oncol 7(11):903–909

    Article  PubMed  Google Scholar 

  • Basch E, Jia X et al (2009) Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 101(23):1624–1632

    Article  PubMed  Google Scholar 

  • Beller E, Tattersall M et al (1997) Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian megestrol acetate cooperative study group. Ann Oncol 8(3):277–283

    Article  PubMed  CAS  Google Scholar 

  • Bergman B, Aaronson NK et al (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life. Eur J Cancer 30A(5):635–642

    Article  PubMed  CAS  Google Scholar 

  • Bergner M, Bobbitt RA et al (1976) The sickness impact profile: Validation of a health status measure. Med Care 14(1):57–67

    Article  PubMed  CAS  Google Scholar 

  • Bergner M, Bobbitt RA et al (1981) The sickness impact profile: Development and final revision of a health status measure. Med Care 19(8):787–805

    Article  PubMed  CAS  Google Scholar 

  • Bezjak A, Dixon P et al (2002) Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Int J Radiat Oncol Biol Phys 54(3):719–728

    Article  PubMed  Google Scholar 

  • Blazeby JM, Brookes ST et al (2001) The prognostic value of quality-of-life scores during treatment for oesophageal cancer. Gut 49(2):227–230

    Article  PubMed  CAS  Google Scholar 

  • Bleehen NM, Girling DJ et al (1991) Inoperable non-small-cell lung cancer (NSCLC): a medical research council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the medical research council by its lung cancer working party. Br J Cancer 63(2):265–270

    Article  Google Scholar 

  • Burris HA 3rd, Moore MJ et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413

    PubMed  CAS  Google Scholar 

  • Cella DF, Tulsky DS (1990) Measuring quality of life today: methodological aspects. Oncology (Williston Park) 4(5):29–38 discussion 69

    CAS  Google Scholar 

  • Cella DF, Tulsky DS et al (1993) The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11(3):570–579

    PubMed  CAS  Google Scholar 

  • Cella DF, Bonomi AE et al (1995) Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer 12(3):199–220

    Article  PubMed  CAS  Google Scholar 

  • Cella D, Eton DT et al (2002) What is a clinically meaningful change on the functional assessment of cancer therapy-lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol 55(3):285–295

    Article  PubMed  Google Scholar 

  • Coates A, Porzsolt F et al (1997) Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33(7):1025–1030

    Article  PubMed  CAS  Google Scholar 

  • Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum Associates, Hillsdale, N. J, L

    Google Scholar 

  • Curran D, Molenberghs G et al (1998) Incomplete quality of life data in randomized trials: Missing forms. Stat Med 17(5–7):697–709

    Article  PubMed  CAS  Google Scholar 

  • Dancey J, Zee B et al (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The national cancer institute of canada clinical trials group. Qual Life Res 6(2):151–158

    Article  PubMed  CAS  Google Scholar 

  • de Graeff A, de Leeuw JR et al (2001) Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 37(3):332–339

    Article  PubMed  Google Scholar 

  • Detmar SB, Muller MJ et al (2002) Health-related quality-of-life assessments and patient–physician communication: a randomized controlled trial. Jama 288(23):3027–3034

    Article  PubMed  Google Scholar 

  • Efficace F, Bottomley A (2005) Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer. J Clin Oncol 23(6):1335–1336 author reply 1336

    Article  PubMed  Google Scholar 

  • Erridge SC, Gaze MN et al (2005) Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 17(1):61–67

    Article  CAS  Google Scholar 

  • Fairclough DL, Peterson HF et al (1998) Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials. Stat Med 17(5–7):781–796

    Article  PubMed  CAS  Google Scholar 

  • Fang FM, Liu YT et al (2004) Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100(2):425–432

    Article  PubMed  Google Scholar 

  • Fayers PM, Curran D et al (1998) Incomplete quality of life data in randomized trials: Missing items. Stat Med 17(5–7):679–696

    Article  PubMed  CAS  Google Scholar 

  • Food and Drug Administration (2009) Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf

    Google Scholar 

  • Ganz PA, Figlin RA et al (1989) Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?. Cancer 63(7):1271–1278

    Article  PubMed  CAS  Google Scholar 

  • Garcia SF, Cella D et al (2007) Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25(32):5106–5112

    Article  PubMed  Google Scholar 

  • Gelber RD, Gelber S (1995) Quality-of-life assessment in clinical trials. Cancer Treat Res 75:225–246

    Article  PubMed  CAS  Google Scholar 

  • Gotay CC (2004) Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer Inst Monogr 2004(33):126–133

    Article  Google Scholar 

  • Guyatt GH, Osoba D et al (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77(4):371–383

    Article  PubMed  Google Scholar 

  • Hahn EA, Webster KA et al (1998) Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: Problems and solutions. Stat Med 17(5–7):547–559

    Article  PubMed  CAS  Google Scholar 

  • Hollen PJ, Gralla RJ et al (1993) Quality of life assessment in individuals with lung cancer: Testing the lung cancer symptom scale (LCSS). Eur J Cancer 29A(Suppl 1):S51–S58

    Article  PubMed  Google Scholar 

  • Hollen PJ, Gralla RJ et al (1994a) Quality of life during clinical trials: Conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 2(4):213–222

    Article  PubMed  CAS  Google Scholar 

  • Hollen PJ, Gralla RJ et al (1994b) Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale. Cancer 73(8):2087–2098

    Article  PubMed  CAS  Google Scholar 

  • Husted JA, Cook RJ et al (2000) Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53(5):459–468

    Article  PubMed  CAS  Google Scholar 

  • Jensen K, Bonde Jensen A et al (2006) The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 78(3):298–305

    Article  PubMed  Google Scholar 

  • Johnson JR, Temple R (1985) Food and drug administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69(10):1155–1159

    PubMed  CAS  Google Scholar 

  • Kaasa S, Mastekaasa A et al (1989) Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients’ subjective experience of disease and psychosocial well-being. Radiother Oncol 15(3):235–242

    Article  PubMed  CAS  Google Scholar 

  • Langendijk H, Aaronson NK et al (2000a) The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 55(1):19–25

    Article  PubMed  CAS  Google Scholar 

  • Langendijk JA, ten Velde GP et al (2000b) Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 47(1):149–155

    Article  PubMed  CAS  Google Scholar 

  • Langendijk JA, Aaronson NK et al (2001) Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol 19(8):2123–2133

    PubMed  CAS  Google Scholar 

  • Langendijk JA, Aaronson NK et al (2002) Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53(4):847–853

    Article  PubMed  Google Scholar 

  • Leitgeb C, Pecherstorfer M et al (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73(10):2535–2542

    Article  PubMed  CAS  Google Scholar 

  • Leplege A, Hunt S (1997) The problem of quality of life in medicine. Jama 278(1):47–50

    Article  PubMed  CAS  Google Scholar 

  • Little RJA, Rubin DB (2002) Statistical analysis with missing data. Hoboken, N.J, Wiley

    Google Scholar 

  • Louie AV, Rodrigues G et al (2010) Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a markov model-based decision analysis. Int J Radiat Oncol Biol Phys doi:10.1016/j.ijrobp.2010.06.040

  • Macbeth FR, Bolger JJ et al (1996) Randomized trial of palliative two-fraction versus more intensive 13 fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical research council lung cancer working party. Clin Oncol (R Coll Radiol) 8(3):167–175

    Article  CAS  Google Scholar 

  • McHorney CA, Ware JE Jr et al (1993) The MOS 36 Item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31(3):247–263

    Article  PubMed  CAS  Google Scholar 

  • McHorney CA, Ware JE Jr et al (1994) The MOS 36 item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66

    Article  PubMed  CAS  Google Scholar 

  • Miller GA (1956) The magical number seven plus or minus two: Some limits on our capacity for processing information. Psychol Rev 63(2):81–97

    Article  PubMed  CAS  Google Scholar 

  • Moinpour CM, Feigl P et al (1989) Quality of life end points in cancer clinical trials: Review and recommendations. J Natl Cancer Inst 81(7):485–495

    Article  PubMed  CAS  Google Scholar 

  • Moinpour CM, Sawyers Triplett J et al (2000) Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psychooncology 9(4):340–354

    Article  PubMed  CAS  Google Scholar 

  • Montazeri A, Milroy R et al (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31(2–3):233–240

    Article  PubMed  CAS  Google Scholar 

  • Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13(3):235–247

    Article  PubMed  Google Scholar 

  • Movsas B, Scott C et al (2005) Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98–01. J Clin Oncol 23(10):2145–2154

    Article  PubMed  CAS  Google Scholar 

  • Movsas B, Moughan J et al (2009) Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol 27(34):5816–5822

    Article  PubMed  Google Scholar 

  • NCI, C. T. C. G. P (1988) Cancer therapy evaluation program: Guidelines. N. C. I. Division of Cancer Treatment, Bethesda, MD

    Google Scholar 

  • Nicklasson M, Bergman B (2007) Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Qual Life Res 16(6):1019–1028

    Article  PubMed  Google Scholar 

  • Norman GR, Sloan JA et al (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582–592

    PubMed  Google Scholar 

  • Nunnaly J, Bernstein I (1994) Psychometric therapy. McGraw-Hill, Mew York

    Google Scholar 

  • Osoba D (1996) Rationale for the timing of health-related quality-of-life (HQL) assessments in oncological palliative therapy. Cancer Treat Rev 22(Suppl A):69–73

    Article  PubMed  Google Scholar 

  • Osoba D, Rodrigues G et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144

    PubMed  CAS  Google Scholar 

  • Pijls-Johannesma M, Houben R et al (2009) High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol 91(3):443–448

    Article  PubMed  Google Scholar 

  • Qian W, Parmar MK et al (2000) Analysis of messy longitudinal data from a randomized clinical trial. MRC lung cancer working party. Stat Med 19(19):2657–2674

    Article  PubMed  CAS  Google Scholar 

  • Ribaudo HJ, Thompson SG (2002) The analysis of repeated multivariate binary quality of life data: a hierarchical model approach. Stat Methods Med Res 11(1):69–83

    Article  PubMed  CAS  Google Scholar 

  • Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127(8 Pt 2):757–763

    Article  PubMed  CAS  Google Scholar 

  • Sadura A, Pater J et al (1992) Quality-of-life assessment: Patient compliance with questionnaire completion. J Natl Cancer Inst 84(13):1023–1026

    Article  PubMed  CAS  Google Scholar 

  • Sales AE, Plomondon ME et al (2004) Assessing response bias from missing quality of life data: the Heckman method. Health Qual Life Outcomes 2:49

    Article  PubMed  Google Scholar 

  • Sarna L, Swann S et al (2008) Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 72(5):1378–1384

    Article  PubMed  Google Scholar 

  • Slevin ML, Plant H et al (1988) Who should measure quality of life, the doctor or the patient?. Br J Cancer 57(1):109–112

    Article  PubMed  CAS  Google Scholar 

  • Sprangers MA, Sloan JA et al (2009) The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 12(3):301–311

    Article  PubMed  Google Scholar 

  • Stewart AL, Ware JE (1992) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham

    Google Scholar 

  • Strain JJ (1990) The evolution of quality of life evaluations in cancer therapy. Oncology (Williston Park) 4(5):22–26 discussion 27

    CAS  Google Scholar 

  • Sundstrom S, Bremnes R et al (2004) Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. J Clin Oncol 22(5):801–810

    Article  PubMed  Google Scholar 

  • Temel JS, Greer JA et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742

    Article  PubMed  CAS  Google Scholar 

  • Testa MA, Simonson DC (1996) Assesment of quality-of-life outcomes. N Engl J Med 334(13):835–840

    Article  PubMed  CAS  Google Scholar 

  • Troxel AB, Fairclough DL et al (1998) Statistical analysis of quality of life with missing data in cancer clinical trials. Stat Med 17(5–7):653–666

    Article  PubMed  CAS  Google Scholar 

  • van der Voort van Zyp NC, Prevost JB et al (2010) Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 77(1):31–37

    Article  Google Scholar 

  • Velikova G, Booth L et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22(4):714–724

    Article  PubMed  Google Scholar 

  • Ware JE Jr, Sherbourne CD (1992) The MOS 36 item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483

    Article  PubMed  Google Scholar 

  • Ware JE, Gandek B et al (1996) Evaluating instruments used cross-nationally: Methods from the IQoLA project. Quality of life and pharmacoeconimics in clinical trials. Raven Press, B. Spilker. New York

    Google Scholar 

  • Watkins-Bruner D, Scott C et al (1995) RTOG’s first quality of life study–RTOG 90–20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 33(4):901–906

    Article  PubMed  CAS  Google Scholar 

  • WHO (1996) Quality of life assessment. The WHOQOL group, 1994. What quality of life? The WHOQOL group. World Health Forum. WHO, Geneva 1996

    Google Scholar 

  • Wyrwich KW (2004) Minimal important difference thresholds and the standard error of measurement: is there a connection?. J Biopharm Stat 14(1):97–110

    Article  PubMed  Google Scholar 

  • Wyrwich KW, Nienaber NA et al (1999a) Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 37(5):469–478

    Article  PubMed  CAS  Google Scholar 

  • Wyrwich KW, Tierney WM et al (1999b) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52(9):861–873

    Article  PubMed  CAS  Google Scholar 

  • Wyrwich KW, Tierney WM et al (2002) Using the standard error of measurement to identify important changes on the Asthma quality of life questionnaire. Qual Life Res 11(1):1–7

    Article  PubMed  Google Scholar 

  • Wyrwich KW, Bullinger M et al (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14(2):285–295

    Article  PubMed  Google Scholar 

  • Zee BC (1998) Growth curve model analysis for quality of life data. Stat Med 17(5–7):757–766

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA

    M. Salim Siddiqui & Benjamin Movsas

  2. Department of Radiation Oncology, Ohio State University, 300 W. 10th Avenue, Columbus, OH, 43210, USA

    Farzan Siddiqui

Authors
  1. M. Salim Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farzan Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin Movsas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin Movsas .

Editor information

Editors and Affiliations

  1. Institute of Lung Diseases, Institutski put 4, Sremska Kamenica, 21204, Serbia

    Branislav Jeremic

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Salim Siddiqui, M., Siddiqui, F., Movsas, B. (2011). Quality of Life Outcomes in Radiotherapy of Lung Cancer. In: Jeremic, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_259

Download citation

  • DOI: https://doi.org/10.1007/174_2011_259

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19924-0

  • Online ISBN: 978-3-642-19925-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation